<html>
<head>PUBMED IDs for NP25</head>
<body bgcolor='#C5F0F2'><h1>NP25</h1><a href='https://pubmed.ncbi.nlm.nih.gov/6242334/'>Impaired AMLR in autoimmunity.</a> May 1  1983<br><a href='https://pubmed.ncbi.nlm.nih.gov/6223969/'>Familial study on &quot;sinking pre-beta&quot;, the Lp(a) lipoprotein, and its relationship with serum lipids, apolipoprotein A-I and B and clinical atherosclerosis.</a> May 1  1983<br><a href='https://pubmed.ncbi.nlm.nih.gov/12049783/'>SM22beta encodes a lineage-restricted cytoskeletal protein with a unique developmentally regulated pattern of expression.</a> June 7  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/17460149/'>sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart.</a> April 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18266473/'>Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility.</a> February 13  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19368828/'>Association of SORL1 gene variants with Alzheimer's disease.</a> November 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/25300797/'>Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.</a> November 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25418192/'>Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.</a> June 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25418156/'>Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy.</a> January 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26738504/'>Roles of low-density lipoprotein receptor-related protein 1 in tumors.</a> December 29  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27825931/'>Quantitative analysis of gene expression changes in response to genotoxic compounds.</a> November 10  2016<br></body></html>
